We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Carbon Nanotube-Based Device Efficiently Transports Nucleic Acids into Cell Cultures

By LabMedica International staff writers
Posted on 25 Apr 2016
A novel device based on carbon nanotubes arranged in "honeycomb-like" structures was used to safely and efficiently transfer genetic material into cultures of different types of human and animal cells.

The introduction of nucleic acids into mammalian cells is a crucial step toward elucidating biochemical pathways and for modifying gene expression and cellular development in immortalized cells, primary cells, and stem cells. More...
Current transfection technologies—such as electrical pulse, gene gun inoculation, and employing viral infection—are time consuming and limited by the size of the genetic cargo that can be transferred, the inefficient introduction of test molecules into large populations of target cells, and the cytotoxicity of the techniques.

Investigators at the University of Rochester (NY, USA) have reported the development of a novel method of introducing genes and biomolecules into tens of thousands of mammalian cells through an array of aligned hollow carbon nanotubes. The device was prepared using the process of chemical vapor deposition that resulted in a structure resembling a nano-sized honeycomb consisting of millions of densely packed carbon nanotubes with openings on both sides of a thin disk shaped membrane.

In a paper published in the April 5, 2016, online edition of the journal Small, the investigators described using the device to culture a series of different human and animal cells. After 48 hours, the cells were bathed in a DNA-enriched liquid medium. The carbon nanotubes acted as conduits drawing the genetic material into the cells in a mild fashion that preserved 98% of the cells with 85% successfully transfected with the new genetic material.

"This represents a very simple, inexpensive, and efficient process that is well tolerated by cells and can successfully deliver DNA into tens of thousands of cells simultaneously," said senior author Dr. Michael Schrlau, assistant professor of engineering at the University of Rochester.

Related Links:
University of Rochester


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.